Prelude Therapeutics PRLD
NASDAQ PRLD
$3.63 +0.03 (+0.83%)
At close: Oct 23, 2026 · 4:00 PM EDT

Prelude Therapeutics (PRLD) Sale and Maturity of Investments (2022 - 2026)

Updated

Analysis

Prelude Therapeutics (PRLD) Sale and Maturity of Investments (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Prelude Therapeutics 289.69 Mn -307.61 Mn - 24.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.46 Mn
Mar 31, 2026 8.50 Mn
Dec 31, 2025 6.40 Mn
Sep 30, 2025 40.09 Mn
Jun 30, 2025 36.21 Mn
Mar 31, 2025 71.70 Mn
Dec 31, 2024 29.50 Mn
Sep 30, 2024 42.79 Mn
Jun 30, 2024 34.36 Mn
Mar 31, 2024 37.00 Mn
Dec 31, 2023 68.25 Mn
Sep 30, 2023 49.75 Mn
Jun 30, 2023 46.50 Mn
Mar 31, 2023 26.00 Mn
Dec 31, 2022 35.00 Mn
Sep 30, 2022 81.36 Mn
Jun 30, 2022 45.08 Mn
Mar 31, 2022 42.50 Mn
API Access

Prelude Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=PRLD&period=max&api_key=YOUR_API_KEY